Atazanavir Sulphate

A complex organic substance that works as an HIV protease inhibitor, which limits the virus’ ability to replicate. With few side effects and a good tolerability, Atazanir was approved by the FDA in 2003 and the EU in 2004.

Formula: C38H52N6O7 • H2SO4

Molecular weight: 802.94 g/mol

Molecular size: Small

Controlled Substance: No

Precursor: No

Indications: Antivirals for systemic use

Status: Commercial

Axano Pharmaceuticals Ltd
contact us now